Means Investment Company’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-4,873
| Closed | -$265K | – | 190 |
|
2022
Q2 | $265K | Sell |
4,873
-193
| -4% | -$10.5K | 0.06% | 162 |
|
2022
Q1 | $276K | Buy |
5,066
+362
| +8% | +$19.7K | 0.05% | 163 |
|
2021
Q4 | $259K | Buy |
4,704
+318
| +7% | +$17.5K | 0.05% | 165 |
|
2021
Q3 | $210K | Buy |
4,386
+9
| +0.2% | +$431 | 0.04% | 176 |
|
2021
Q2 | $218K | Sell |
4,377
-232
| -5% | -$11.6K | 0.04% | 176 |
|
2021
Q1 | $206K | Sell |
4,609
-61
| -1% | -$2.73K | 0.05% | 170 |
|
2020
Q4 | $206K | Buy |
4,670
+11
| +0.2% | +$485 | 0.05% | 173 |
|
2020
Q3 | $215K | Buy |
4,659
+10
| +0.2% | +$461 | 0.06% | 138 |
|
2020
Q2 | $240K | Buy |
4,649
+5
| +0.1% | +$258 | 0.08% | 126 |
|
2020
Q1 | $243K | Sell |
4,644
-136
| -3% | -$7.12K | 0.09% | 114 |
|
2019
Q4 | $286K | Buy |
4,780
+10
| +0.2% | +$598 | 0.1% | 119 |
|
2019
Q3 | $269K | Sell |
4,770
-26
| -0.5% | -$1.47K | 0.1% | 121 |
|
2019
Q2 | $244K | Buy |
4,796
+498
| +12% | +$25.3K | 0.1% | 123 |
|
2019
Q1 | $225K | Buy |
4,298
+9
| +0.2% | +$471 | 0.1% | 126 |
|
2018
Q4 | $205K | Buy |
+4,289
| New | +$205K | 0.11% | 121 |
|